Suppr超能文献

囊性棘球蚴病管理的新选择——单中心使用微创技术的经验

New Options in the Management of Cystic Echinococcosis - A Single Centre Experience Using Minimally Invasive Techniques.

作者信息

Popa Alexandru Cosmin, Akhan Okan, Petruţescu Marius Septimiu, Popa Loredana Gabriela, Constantin Corina, Mihăilescu Patricia, Creţu Carmen Michaela, Botezatu Cristian, Mastalier Bogdan

出版信息

Chirurgia (Bucur). 2018 Jul-Aug;113(4):486-496. doi: 10.21614/chirurgia.113.4.486.

Abstract

OBJECTIVE

The aim of this study is to verify if the experience on 4 years in using minimally invasive techniques in the treatment of CE could match regarding the indications and results with the major studies on topic.

METHOD

During 03.2014 - 03. 2018 period, 38 PAIR, 28 MoCaT procedures and 7 percutaneous drainages have been performed at 51 patients from 76 cases of hydatid hepatic cysts (67,1%). There were 26 men and 25 women, and the age ranged from 19 to 78. 7 patients have had 2 hydatid hepatic cysts or more and 2 procedures were performed at 3 of those patients; other 11 patients needed the second procedure during the surveillance. The evolution of the patients was favorable, and the surveillance was 2 years postintervention at least. There were no major surgical adverse effects. We defined as an expected result obtaining a scar lesion or a small cavity with calcified walls (hyperechoic). Only 2 (3,9%) patients needed conversion to open surgery. The complications we have faced were represented by the cystic-biliary fistula in 15 cases (29,4%) and the re-opening of the cyst's cavity in 11 cases (21,67%). The percutaneous treatment of CE is safe and effective, following the correct assignation according with the cysts type. The percutaneous treatment of CE is an easier alternative to the open surgery and has lower rate of complications and relapses, and a shorter hospitalisation. Now routine, it becomes slighty the first option for invasive treatment of CE. The role of open surgery is restricted to CE with severe complications.

摘要

目的

本研究的目的是验证在治疗肝包虫病中使用微创技术4年的经验在适应症和结果方面是否能与该主题的主要研究相匹配。

方法

在2014年3月至2018年3月期间,对76例肝包虫囊肿患者中的51例(67.1%)进行了38例经皮穿刺抽吸注射硬化治疗(PAIR)、28例改良根治性经皮穿刺治疗(MoCaT)和7例经皮引流。其中男性26例,女性25例,年龄在19至78岁之间。7例患者有2个或更多的肝包虫囊肿,其中3例患者进行了2次手术;其他11例患者在随访期间需要进行第二次手术。患者的病情进展良好,干预后至少随访2年。未出现重大手术不良反应。我们将获得瘢痕性病变或有钙化壁(高回声)的小腔定义为预期结果。只有2例(3.9%)患者需要转为开放手术。我们遇到的并发症包括15例(29.4%)的胆瘘和11例(21.67%)的囊肿腔重新开放。根据囊肿类型进行正确分类后,肝包虫病的经皮治疗是安全有效的。肝包虫病的经皮治疗是开放手术的一种更简便的替代方法,并发症和复发率较低,住院时间较短。现在它已成为常规治疗,逐渐成为肝包虫病侵入性治疗的首选。开放手术的作用仅限于治疗有严重并发症的肝包虫病。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验